Inclusion Criteria:  Breast cancer survivor stage I-III Symptomatic for neuropathy postural control outside 70% CI for adults who are middle-aged without neurotrauma having completed taxane-based chemotherapy treatment at least 3 months ago; able to understand and comply with directions associated with testing and study treatments.  Exclusion Criteria:  Pre-existing vestibular deficit; poorly controlled diabetes (hgA1C > 8); non-ambulatory or lower extremity amputation (assistive devices allowed); use of cytotoxic or immunotherapy during study (endocrine therapy allowed); participation in physical therapy during the study; contraindication to participate in Tango due to orthopedic issue (e.g., herniated vertebral disc);